|Bid||0.00 x N/A|
|Ask||0.00 x N/A|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||0.94|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
DEERFIELD, Ill., March 01, 2022--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Barclays Global Healthcare Conference on Thursday, March 17, 2022. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:00 a.m. Eastern Time.
DEERFIELD, Ill., March 01, 2022--Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, announced today new data indicating the use of Baxter’s Sharesource remote patient management platform with an automated peritoneal dialysis (APD) cycler may improve the clinical effectiveness of home kidney patients care by extending their time on therapy by 3.4 months.